Erle T. Mast
2013
In 2013, Erle T. Mast earned a total compensation of $1.6M as EVP, Chief Financial Officer at Clovis Oncology, a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $222,780 |
|---|---|
| Option Awards | $1,018,433 |
| Salary | $369,500 |
| Other | $15,255 |
| Total | $1,625,968 |
Mast received $1M in option awards, accounting for 63% of the total pay in 2013.
Mast also received $222.8K in bonus, $369.5K in salary and $15.3K in other compensation.
Rankings
In 2013, Erle T. Mast's compensation ranked 4,618th out of 12,286 executives tracked by ExecPay. In other words, Mast earned more than 62.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,618 out of 12,286 | 62nd |
Division Manufacturing | 1,583 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 458 out of 1,466 | 69th |
Industry group Drugs | 319 out of 1,160 | 73rd |
Industry Pharmaceutical Preparations | 256 out of 890 | 71st |
Source: SEC filing on April 27, 2016.
Mast's colleagues
We found four more compensation records of executives who worked with Erle T. Mast at Clovis Oncology in 2013.